Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today?
PBLA stock is down on a public offering Panbela Therapeutics (NASDAQ:PBLA) stock is falling on Monday after the clinical-stage biopharmaceutical company revealed the pricing of a public offering for its shares. Panbela Therapeutics is selling 4,375,000 shares of its common stock for $2.06 each.…
#pbla #panbelatherapeutics #williamwhite